Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
出版年份 2016 全文链接
标题
Virus-like particles derived from Pichia pastoris-expressed dengue virus type 1 glycoprotein elicit homotypic virus-neutralizing envelope domain III-directed antibodies
作者
关键词
Virus-like particles, Dengue virus, Envelope glycoprotein, Envelope domain III, <em class=EmphasisTypeItalic >Pichia pastoris</em>, Neutralizing antibody, Antibody dependent enhancement
出版物
BMC BIOTECHNOLOGY
Volume 16, Issue 1, Pages -
出版商
Springer Nature
发表日期
2016-06-14
DOI
10.1186/s12896-016-0280-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dengue Virus Infection with Highly Neutralizing Levels of Cross-Reactive Antibodies Causes Acute Lethal Small Intestinal Pathology without a High Level of Viremia in Mice
- (2015) Satoru Watanabe et al. JOURNAL OF VIROLOGY
- Dengue vaccine: hypotheses to understand CYD-TDV-induced protection
- (2015) Bruno Guy et al. NATURE REVIEWS MICROBIOLOGY
- Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America
- (2015) Luis Villar et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies
- (2015) Lav Tripathi et al. Frontiers in Microbiology
- Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial
- (2014) Maria Rosario Capeding et al. LANCET
- Dengue Viruses Are Enhanced by Distinct Populations of Serotype Cross-Reactive Antibodies in Human Immune Sera
- (2014) Ruklanthi de Alwis et al. PLoS Pathogens
- Functional Analysis of Antibodies against Dengue Virus Type 4 Reveals Strain-Dependent Epitope Exposure That Impacts Neutralization and Protection
- (2013) S. Sukupolvi-Petty et al. JOURNAL OF VIROLOGY
- Dengue vaccine efficacy trial: does interference cause failure?
- (2013) Sathyamangalam Swaminathan et al. LANCET INFECTIOUS DISEASES
- The global distribution and burden of dengue
- (2013) Samir Bhatt et al. NATURE
- Adaptive immune activation: glycosylation does matter
- (2013) Margreet A Wolfert et al. Nature Chemical Biology
- Pichia pastoris-Expressed Dengue 2 Envelope Forms Virus-Like Particles without Pre-Membrane Protein and Induces High Titer Neutralizing Antibodies
- (2013) Shailendra Mani et al. PLoS One
- Unique challenges faced by the clinical evaluation of dengue vaccines
- (2011) Robert Edelman Expert Review of Vaccines
- The Necessity and Quandaries of Dengue Vaccine Development
- (2011) S. J. Thomas JOURNAL OF INFECTIOUS DISEASES
- Persistence of Circulating Memory B Cell Clones with Potential for Dengue Virus Disease Enhancement for Decades following Infection
- (2011) S. A. Smith et al. JOURNAL OF VIROLOGY
- Next generation dengue vaccines: A review of candidates in preclinical development
- (2011) Julia Schmitz et al. VACCINE
- Dengue vaccines: state of the art
- (2010) Sathyamangalam Swaminathan et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Genotype-Specific Neutralization and Protection by Antibodies against Dengue Virus Type 3
- (2010) James D. Brien et al. JOURNAL OF VIROLOGY
- Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans
- (2010) W. Dejnirattisai et al. SCIENCE
- Immature Dengue Virus: A Veiled Pathogen?
- (2010) Izabela A. Rodenhuis-Zybert et al. PLoS Pathogens
- Natural Strain Variation and Antibody Neutralization of Dengue Serotype 3 Viruses
- (2010) Wahala M. P. B. Wahala et al. PLoS Pathogens
- The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1
- (2010) Bimmi Shrestha et al. PLoS Pathogens
- Dengue: Recent Advances in Biology and Current Status of Translational Research
- (2009) Sathyamangalam Swaminathan et al. CURRENT MOLECULAR MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started